Russia's Sputnik V gets approval in India; Here's everything you need to know!

New Delhi: There is a big news coming out in the country amid complaints of growing outbreak of Corona and lack of vaccine. Emergency use of Russia's Corona vaccine Sputnik V has been approved. DCGI has approved the use of Russia's vaccine Sputnik V on Tuesday.

Sputnik V gets approval in India:

India has become the 60th country in the world to use this vaccine against the corona virus. Phase III of the local clinical trial of this vaccine was completed in collaboration with the doctor Reddy Lab in the country. Now finally the central agency has approved its emergency use.

Sputnik-V is 91.6% effective:

Russia's Gamalaya Research Institute claims 91.6 percent of the vaccine to be effective. Covishield being used in the country is only 80 percent and covaxin 81 percent effective. Its one dose is priced at Rs 700. Russia approved for use in August last year. It has been approved for use in more than 60 countries including Serbia, Argentina, Volivia.

Russian Ambassador to India Nikolay Kudassev justified the recommendation for the use of Sputnik-V, saying the move would definitely contribute to the Indian government's efforts to counter the covid-19 pandemic.

Kirill, CEO of the Russian Direct Investment Fund, said in a statement that we welcome India's decision to grant emergency approval to Sputnik V. He further stated that the Russian vaccine is 91.6 percent effective in fighting against the corona and that this vaccine will prove to be helpful in cases of severe corona.

ccording to test results, Sputnik-V vaccine deficiency is 100 percent effective in preventing symptoms and deaths from infection. It is expected that this vaccine will help prevent the uncontrollable pandemic in the country. The severity of infection is seen to be controlled by the people who are getting the vaccine.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.